[EN] PHOSPHOLIPASE C INHIBITORS FOR USE IN TREATING INFLAMMATORY DISORDERS<br/>[FR] INHIBITEURS DE PHOSPHLOLIPASE C DESTINES A ETRE UTILISE DANS LE TRAITEMENT DE TROUBLES INFLAMMATOIRES
申请人:JANSSEN PHARMACEUTICA NV
公开号:WO2004087685A2
公开(公告)日:2004-10-14
This invention is directed to heterocyclyl-substituted anilino phospholipase C inhibitor compounds and enantiomers, diastereomers and pharmaceutically acceptable salts thereof useful in treating or ameliorating an inflammatory disorders and/or restenosis. The present invention is further directed to pharmaceutical compositions comprising the compounds of the present invention and to methods for treating conditions affected by phospholipase modulation.